Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis
Background: Dilated cardiomyopathy (DCM) is one of the main causes of systolic heart failure and frequently has a genetic component. The molecular mechanisms underlying the onset and progression of DCM remain unclear. This study aimed to identify novel diagnostic biomarkers to aid in the treatment a...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-08-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/27/8/10.31083/j.fbl2708246 |
_version_ | 1817981606906822656 |
---|---|
author | Qixin Guo Qiang Qu Luyang Wang Shengen Liao Xu Zhu Anning Du Qingqing Zhu Iokfai Cheang Rongrong Gao Xinli Li |
author_facet | Qixin Guo Qiang Qu Luyang Wang Shengen Liao Xu Zhu Anning Du Qingqing Zhu Iokfai Cheang Rongrong Gao Xinli Li |
author_sort | Qixin Guo |
collection | DOAJ |
description | Background: Dilated cardiomyopathy (DCM) is one of the main causes of systolic heart failure and frequently has a genetic component. The molecular mechanisms underlying the onset and progression of DCM remain unclear. This study aimed to identify novel diagnostic biomarkers to aid in the treatment and diagnosis of DCM. Method: The Gene Expression Omnibus (GEO) database was explored to extract two microarray datasets, GSE120895 and GSE17800, which were subsequently merged into a single cohort. Differentially expressed genes were analyzed in the DCM and control groups, followed by weighted gene coexpression network analysis to determine the core modules. Core nodes were identified by gene significance (GS) and module membership (MM) values, and four hub genes were predicted by the Lasso regression model. The expression levels and diagnostic values of the four hub genes were further validated in the datasets GSE19303. Finally, potential therapeutic drugs and upstream molecules regulating genes were identified. Results: The turquoise module is the core module of DCM. Four hub genes were identified: GYPC (glycophorin C), MLF2 (myeloid leukemia factor 2), COPS7A (COP9 signalosome subunit 7A) and ARL2 (ADP ribosylation factor like GTPase 2). Subsequently, Hub genes showed significant differences in expression in both the dataset and the validation model by real-time quantitative PCR (qPCR). Four potential modulators and seven chemicals were also identified. Finally, molecular docking simulations of the gene-encoded proteins with small-molecule drugs were successfully performed. Conclusions: The results suggested that ARL2, MLF2, GYPC and COPS7A could be potential gene biomarkers for DCM. |
first_indexed | 2024-04-13T23:08:13Z |
format | Article |
id | doaj.art-53fb85e80c6e47f397228a05c3eda04a |
institution | Directory Open Access Journal |
issn | 2768-6701 |
language | English |
last_indexed | 2024-04-13T23:08:13Z |
publishDate | 2022-08-01 |
publisher | IMR Press |
record_format | Article |
series | Frontiers in Bioscience-Landmark |
spelling | doaj.art-53fb85e80c6e47f397228a05c3eda04a2022-12-22T02:25:37ZengIMR PressFrontiers in Bioscience-Landmark2768-67012022-08-0127824610.31083/j.fbl2708246S2768-6701(22)00596-2Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network AnalysisQixin Guo0Qiang Qu1Luyang Wang2Shengen Liao3Xu Zhu4Anning Du5Qingqing Zhu6Iokfai Cheang7Rongrong Gao8Xinli Li9Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, ChinaBackground: Dilated cardiomyopathy (DCM) is one of the main causes of systolic heart failure and frequently has a genetic component. The molecular mechanisms underlying the onset and progression of DCM remain unclear. This study aimed to identify novel diagnostic biomarkers to aid in the treatment and diagnosis of DCM. Method: The Gene Expression Omnibus (GEO) database was explored to extract two microarray datasets, GSE120895 and GSE17800, which were subsequently merged into a single cohort. Differentially expressed genes were analyzed in the DCM and control groups, followed by weighted gene coexpression network analysis to determine the core modules. Core nodes were identified by gene significance (GS) and module membership (MM) values, and four hub genes were predicted by the Lasso regression model. The expression levels and diagnostic values of the four hub genes were further validated in the datasets GSE19303. Finally, potential therapeutic drugs and upstream molecules regulating genes were identified. Results: The turquoise module is the core module of DCM. Four hub genes were identified: GYPC (glycophorin C), MLF2 (myeloid leukemia factor 2), COPS7A (COP9 signalosome subunit 7A) and ARL2 (ADP ribosylation factor like GTPase 2). Subsequently, Hub genes showed significant differences in expression in both the dataset and the validation model by real-time quantitative PCR (qPCR). Four potential modulators and seven chemicals were also identified. Finally, molecular docking simulations of the gene-encoded proteins with small-molecule drugs were successfully performed. Conclusions: The results suggested that ARL2, MLF2, GYPC and COPS7A could be potential gene biomarkers for DCM.https://www.imrpress.com/journal/FBL/27/8/10.31083/j.fbl2708246weighted gene coexpression network analysisdilated cardiomyopathy |
spellingShingle | Qixin Guo Qiang Qu Luyang Wang Shengen Liao Xu Zhu Anning Du Qingqing Zhu Iokfai Cheang Rongrong Gao Xinli Li Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis Frontiers in Bioscience-Landmark weighted gene coexpression network analysis dilated cardiomyopathy |
title | Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis |
title_full | Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis |
title_fullStr | Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis |
title_full_unstemmed | Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis |
title_short | Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis |
title_sort | identification of potential biomarkers associated with dilated cardiomyopathy by weighted gene coexpression network analysis |
topic | weighted gene coexpression network analysis dilated cardiomyopathy |
url | https://www.imrpress.com/journal/FBL/27/8/10.31083/j.fbl2708246 |
work_keys_str_mv | AT qixinguo identificationofpotentialbiomarkersassociatedwithdilatedcardiomyopathybyweightedgenecoexpressionnetworkanalysis AT qiangqu identificationofpotentialbiomarkersassociatedwithdilatedcardiomyopathybyweightedgenecoexpressionnetworkanalysis AT luyangwang identificationofpotentialbiomarkersassociatedwithdilatedcardiomyopathybyweightedgenecoexpressionnetworkanalysis AT shengenliao identificationofpotentialbiomarkersassociatedwithdilatedcardiomyopathybyweightedgenecoexpressionnetworkanalysis AT xuzhu identificationofpotentialbiomarkersassociatedwithdilatedcardiomyopathybyweightedgenecoexpressionnetworkanalysis AT anningdu identificationofpotentialbiomarkersassociatedwithdilatedcardiomyopathybyweightedgenecoexpressionnetworkanalysis AT qingqingzhu identificationofpotentialbiomarkersassociatedwithdilatedcardiomyopathybyweightedgenecoexpressionnetworkanalysis AT iokfaicheang identificationofpotentialbiomarkersassociatedwithdilatedcardiomyopathybyweightedgenecoexpressionnetworkanalysis AT rongronggao identificationofpotentialbiomarkersassociatedwithdilatedcardiomyopathybyweightedgenecoexpressionnetworkanalysis AT xinlili identificationofpotentialbiomarkersassociatedwithdilatedcardiomyopathybyweightedgenecoexpressionnetworkanalysis |